<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5545592</article-id><article-id pub-id-type="doi">10.3389/fimmu.2017.00928</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Neutrophil Extracellular Traps and Endothelial Dysfunction in Atherosclerosis and Thrombosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Qi</surname><given-names>Haozhe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/435824"/></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Shuofei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="author-notes" rid="fn001"><sup>&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Lan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="author-notes" rid="fn001"><sup>&#x02020;</sup></xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Jixin Zhong, Case Western Reserve University, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Hugo Caire Castro-Faria-Neto, Oswaldo Cruz Foundation, Brazil; Neha Dixit, DiscoveRx, United States; Shanzhong Gong, University of Texas at Austin, United States</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Shuofei Yang, <email>yangshuofei@gmail.com</email>; Lan Zhang, <email>zhanglanrjxg@gmail.com</email></corresp><fn fn-type="other" id="fn001"><p><sup>&#x02020;</sup>These authors have contributed equally to this work.</p></fn><fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>8</volume><elocation-id>928</elocation-id><history><date date-type="received"><day>08</day><month>5</month><year>2017</year></date><date date-type="accepted"><day>20</day><month>7</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 Qi, Yang and Zhang.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Qi, Yang and Zhang</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Cardiovascular diseases are a leading cause of mortality and morbidity worldwide. Neutrophils are a component of the innate immune system which protect against pathogen invasion; however, the contribution of neutrophils to cardiovascular disease has been underestimated, despite infiltration of leukocyte subsets being a known driving force of atherosclerosis and thrombosis. In addition to their function as phagocytes, neutrophils can release their extracellular chromatin, nuclear protein, and serine proteases to form net-like fiber structures, termed neutrophil extracellular traps (NETs). NETs can entrap pathogens, induce endothelial activation, and trigger coagulation, and have been detected in atherosclerotic and thrombotic lesions in both humans and mice. Moreover, NETs can induce endothelial dysfunction and trigger proinflammatory immune responses. Overall, current data indicate that NETs are not only present in plaques and thrombi but also have causative roles in triggering formation of atherosclerotic plaques and venous thrombi. This review is focused on published findings regarding NET-associated endothelial dysfunction during atherosclerosis, atherothrombosis, and venous thrombosis pathogenesis. The NET structure is a novel discovery that will find its appropriate place in our new understanding of cardiovascular disease. In addition, NETs have high potential to be further explored toward much better treatment of atherosclerosis and venous thromboembolism in clinic.</p></abstract><kwd-group><kwd>neutrophil extracellular traps</kwd><kwd>endothelial dysfunction</kwd><kwd>atherosclerosis</kwd><kwd>atherothrombosis</kwd><kwd>venous thromboembolism</kwd></kwd-group><funding-group><award-group><funding-source id="cn01">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></funding-source><award-id rid="cn01">81670442</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="94"/><page-count count="9"/><word-count count="6976"/></counts></article-meta></front><body><sec id="S1"><title>Highlights</title><list list-type="order"><list-item><p>The NET structure, which has been clearly observed in the atherosclerotic plaque and venous thrombi, is a novel discovery that will find its appropriate place in our new understanding of cardiovascular disease.</p></list-item><list-item><p>This review summarizes the crosstalk mechanism between NETs and endothelial cells during the thrombosis and atherosclerosis.</p></list-item><list-item><p>NETs have high potential to be further explored to progress toward much better treatment of atherosclerosis and venous thromboembolism in clinic.</p></list-item></list></sec><sec sec-type="introduction" id="S2"><title>Introduction</title><p>Polymorphonuclear neutrophils (PMNs) have a significant innate immune system function in protection against pathogen invasion. In addition to classical phagocytosis, PMNs can release chromatin, nuclear proteins, and serine proteases extracellularly to form [neutrophil extracellular traps (NETs)], which comprise net-like DNA fibers containing histones and antimicrobial proteins (<xref rid="B1" ref-type="bibr">1</xref>). NETs can entrap pathogens to limit their dispersion, trigger coagulation, and induce endothelial injury. Since the first characterization of NETs in 2004, studies of their effects have expanded to reveal unexpected roles in sterile inflammation induced by PMNs (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). Notably, the antibacterial activity of NETs is abrogated by deoxyribonuclease (DNase), which can directly degrade the chromatin fibers that comprise the backbone of NETs (<xref rid="B2" ref-type="bibr">2</xref>). Vascular endothelial cells (ECs) maintain the balance between anticoagulation and immune response functions. Atherosclerosis and venous thromboembolism (VTE) are two major cardiovascular diseases associated with endothelial dysfunction. Atherosclerosis and thrombosis share many common risk factors, such as obesity, diabetes, smoking, hypertension, and hyperlipidemia; however, it remains unclear whether there are specific factors involved in the pathogenesis of both atherosclerosis and VTE (<xref rid="B4" ref-type="bibr">4</xref>).</p><p>Neutrophil extracellular traps can be detected in both atherosclerosis and thrombosis, and the existence of these structures could be perceived as a double-edged sword in the context of disease processes, as it may both attenuate tissue injury and amplify local inflammation, leading to deterioration in disease symptoms (<xref rid="B5" ref-type="bibr">5</xref>). Nevertheless, no specific explanations are available for the effects of NETs on vascular endothelial function and the promotion of atherosclerosis and thrombosis. In this review, we reveal potential mechanisms underlying NET formation and endothelial dysfunction in cardiovascular disease and examine current knowledge of the potential clinical implications of these structures.</p></sec><sec id="S3"><title>Mechanism of NET Formation</title><p>Neutrophil extracellular traps are formed during inflammation and observed <italic>in vivo</italic> during infections (<xref rid="B6" ref-type="bibr">6</xref>). The existence of NETs indicates that PMNs may undergo an alternative form of programmed cell death, termed NETosis, allowing function of these structures in innate immune defense. Depending on the different triggers involved, signaling molecule receptors and membrane integrity, NETosis is described as either &#x0201c;vital&#x0201d; or &#x0201c;suicidal&#x0201d; (<xref rid="B7" ref-type="bibr">7</xref>&#x02013;<xref rid="B11" ref-type="bibr">11</xref>). In &#x0201c;vital&#x0201d; NETosis, PMNs rapidly release nuclear DNA encircled by vesicles to the extracellular space without membrane perforation, in response to stimulation by platelets <italic>via</italic> toll-like receptor (TLR)-4, or Gram-positive bacteria <italic>via</italic> TLR-2, in a reactive oxygen species (ROS)-independent manner (<xref rid="B12" ref-type="bibr">12</xref>). &#x0201c;Suicidal&#x0201d; NETosis is characterized by strong activation of nicotinamide adenine dinucleotide phosphate oxidase by phorbol 12-myristate 13-acetate, interleukin-8 (IL-8), or various microbial pathogens, in a ROS-dependent manner (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>). NETs can be released <italic>via</italic> neutrophil lysis or through vesicular transport of nuclear or mitochondrial DNA, without membrane rupture (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B15" ref-type="bibr">15</xref>). Regardless of which type of NET occurs, the molecular contents of their structures are similar, and include histones, neutrophil elastase (NE), myeloperoxidase (MPO), proteinase 3, cathepsin, and gelatinase (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>).</p><p>Although neutrophils are transcriptionally active cells, the majority of their DNA is transcriptionally inactive and condensed into heterochromatin. Its decondensation is mediated by peptidyl arginine deiminase 4 (PAD4), which catalyzes the conversion of histone arginines to citrullines, reducing the strong positive charge of histones, and consequently weakening histone-DNA binding (<xref rid="B18" ref-type="bibr">18</xref>). Spikes in intracellular Ca<sup>2+</sup> can activate PAD4 to propagate NET release, and PAD4-deficient mice are unable to form NETs in response to physiological activators, such as bacteria (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>). NE is considered essential for histone cleavage during NETosis; accordingly, secretory leukocyte peptidase inhibitor, an endogenous elastase inhibitor, can inhibit NETosis (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B21" ref-type="bibr">21</xref>). The central role of elastase in NETosis is corroborated by the inability of PMNs from elastase-deficient mice to undergo this process (<xref rid="B22" ref-type="bibr">22</xref>).</p></sec><sec id="S4"><title>NETs and Atherosclerosis</title><p>Atherosclerosis is a cardiovascular disease accompanied by chronic vascular wall inflammation, endothelial dysfunction, and smooth muscle cell proliferation (<xref rid="B23" ref-type="bibr">23</xref>). Given the limited lifespan of PMNs and inadequate methods for their detection, the contribution of neutrophils to atherosclerosis has been underestimated (<xref rid="B24" ref-type="bibr">24</xref>). Additionally, the phenotype of PMNs can alter in response to inflammation, which has also resulted in the historical neglect of the role of neutrophils in the process of atherosclerosis (Figure <xref ref-type="fig" rid="F1">1</xref>A) (<xref rid="B25" ref-type="bibr">25</xref>). Hyperlipidemia can injure ECs, promoting lipid deposition and plaque formation, and usually represents the onset of atherosclerosis. Interestingly, hyperlipidemia induces neutrophilia, which is positively associated with atherosclerotic plaque burden (<xref rid="B24" ref-type="bibr">24</xref>). In addition, hypercholesterolemia can induce the synthesis of granulocyte colony-stimulating factor (G-CSF), a key cytokine in the regulation of granulopoiesis, through inducing increased levels of tumor necrosis factor-&#x003b1; and interleukin-17 (IL-17) (<xref rid="B26" ref-type="bibr">26</xref>). G-CSF stimulates the proliferation of myeloid precursors and reduces bone marrow C-X-C motif ligand (CXCL)-12 levels, thereby reducing the clearance of aged PMNs (<xref rid="B27" ref-type="bibr">27</xref>). In addition, hypercholesterolemia can enhance serum levels of CXCL1, which promotes PMN mobilization (<xref rid="B28" ref-type="bibr">28</xref>). Together, these data suggest that PMNs may play a role in stimulation of atherosclerosis.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>NETosis interweaves atherosclerosis and thrombosis. <bold>(A)</bold> Neutrophil extracellular traps (NETs) are involved in the whole process of atherosclerosis. The myeloperoxidase from NTEs can stimulate macrophage to oxidize low-density lipoprotein (LDL) to ox-LDL and form the foam cell. The hyperlipidemia recruits neutrophil into circulation from bone marrow by upregulating the expression of granulocyte colony-stimulating factor and downregulating the level of C-X-C motif ligand -12, which is an important signal for the clearance and recruitment of aged neutrophils to the bone marrow. Cholesterol crystals can trigger the polymorphonuclear neutrophil (PMN) to release the NETs that prime the macrophages for pro-inflammatory cytokine production including IL-1&#x003b2;. Then IL-1&#x003b2; activates Th17&#x02009;cell to release interleukin-17, amplifying the immune cell recruitment into the atherosclerotic plaque. As another critical source of foam cell, SMC also takes part in atherosclerosis. However, there are few reports about the interaction between NETs and SMC. <bold>(B)</bold> NETs are released from PMNs, which are activated by LPS or other cytokines from injured endothelial cells. NETs promote the expression of von Willebrand factor and P-selectin on the surface of venous endothelium to entrap both platelets and red blood cells, thereby creating a scaffold for fibrin deposition. Meanwhile, histones and TF from the NETs structure induce the thrombin generation and activation <italic>via</italic> platelet-dependent or -independent mechanism. Tissue factor pathway inhibitor (TFPI) can abrogate the function of TF. However, utrophil elastase from NETs could degrade TFPI, antithrombin, and activated protein C.</p></caption><graphic xlink:href="fimmu-08-00928-g001"/></fig><p>Recent studies have indicated that PMNs attach themselves to atherosclerotic plaques, primarily through NET formation (Figure <xref ref-type="fig" rid="F1">1</xref>A). Components of NETs, such as cathepsin G and cathelicidins, exhibit monocyte-attracting activity in atherosclerotic plaques (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>). The cathelicidin-related antimicrobial peptide (CRAMP) residing in neutrophil secondary granules have potent effects on recruitment and activation of immune cells, such as monocytes and dendritic cells (<xref rid="B31" ref-type="bibr">31</xref>). NET-derived CRAMP-deleted ApoE-deficient mice develop smaller plaques than ApoE-deficient mice, suggesting that CRAMP may be involved in plaque formation (<xref rid="B32" ref-type="bibr">32</xref>). Moreover, NETs have been identified as a major source of CRAMP, which is deposited directly on the inflamed endothelial surface in atherosclerotic vessels. Indeed, NET-derived CRAMP anchors to ECs, where it can link with formyl-peptide receptor 2 on classical monocytes, resulting in monocyte recruitment to ECs (<xref rid="B33" ref-type="bibr">33</xref>). After binding to the mannose receptor of macrophages, MPO from NETs induces the release of ROS, along with other pro-inflammatory macrophage-derived cytokines (<xref rid="B23" ref-type="bibr">23</xref>). Furthermore, proteinases from NETs affect plaque instability, while ROS from macrophages contributes to the modification of low-density lipoprotein (LDL) to produce ox-LDL, which promotes the development of foam cells (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>). NETs can also regulate cytokine production from macrophages in atherosclerosis (<xref rid="B36" ref-type="bibr">36</xref>). More precisely, cholesterol crystals function as danger signals, inducing interleukin-1&#x003b2; (IL-1&#x003b2;) production and triggering NET release from PMNs. Subsequently, NETs stimulate cytokine release from macrophages and activate T helper 17 cells, resulting in amplified immune cell recruitment to the atherosclerotic plaque (<xref rid="B36" ref-type="bibr">36</xref>).</p><p>Research has underscored the importance of NETs in the regulation of lesion size in atherosclerosis, and suggests that these structures can induce endothelial dysfunction directly by activation and damage of ECs (<xref rid="B37" ref-type="bibr">37</xref>). Inhibition of PAD4 using chloramidine led to decreased atherosclerotic lesion size and carotid artery thrombosis delay in a mouse model, while these effects were not observed after treatment with neutrophil-depleting antibody, or of mice lacking a functional type I interferon receptor (<xref rid="B37" ref-type="bibr">37</xref>). These data indicate a critical direct role for NETs in atherosclerotic lesion formation <italic>via</italic> type I interferon. Mixture of cell free-DNA and granule proteins can stimulate plasmacytoid dendritic cells, leading to a strong type I interferon response and a deteriorating atherosclerotic plaque burden; however, the importance of the NET-derived type I interferon response in atherogenesis has been questioned, because NETs can also regulate cytokine production by macrophages in atherosclerosis (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>).</p></sec><sec id="S5"><title>NETs and Atherothrombosis</title><p>Atherothrombosis is the formation of a thrombus within an artery with atherosclerosis. Neutrophils as well as macrophages participate importantly in this disease process. In most cases, atherothrombosis follows rupture of atheroma, which may be triggered by NETs (<xref rid="B8" ref-type="bibr">8</xref>). Circulating leukocytes have a crucial role in atherothrombosis and systemic neutrophil counts are robust predictors of acute coronary events (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>). Moreover, complement activation can trigger PMN recruitment to the site of atherothrombosis in acute myocardial infarction (<xref rid="B42" ref-type="bibr">42</xref>). Coronary atherothrombosis specimens from patients with acute myocardial infarction contain numerous activated neutrophils (<xref rid="B43" ref-type="bibr">43</xref>&#x02013;<xref rid="B45" ref-type="bibr">45</xref>). Sudden rupture of atherosclerotic plaques triggers platelet aggregation and fibrin deposition at the initial site of atherothrombosis to entrap circulating red blood cells. The interaction of thrombin-activated platelets with PMNs at the site of plaque rupture during acute ST-segment elevation acute myocardial infarction results in local formation of NETs (<xref rid="B46" ref-type="bibr">46</xref>). Elevated levels of circulating DNA and chromatin released from activated PMNs are independently associated with severe coronary atherosclerosis and the prothrombotic state (<xref rid="B47" ref-type="bibr">47</xref>). Interestingly, NETs are frequently found in lytic and fresh thrombus specimens, but never observed in organized thrombus (<xref rid="B48" ref-type="bibr">48</xref>). Hence, it can be assumed that NETs are involved at an early stage during the formation of coronary thrombus and lytic changes. A recent study involving evaluation of coronary atherothrombosis specimens demonstrated that NET burden and DNase activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size (<xref rid="B49" ref-type="bibr">49</xref>).</p><p>Histological analysis of 26 thrombectomy samples from patients with acute myocardial infarction revealed that activated platelets present high-mobility group box 1 protein to PMNs, thereby inducing NET formation (<xref rid="B50" ref-type="bibr">50</xref>). The authors speculate that these NETs may contribute to plaque rupture and subsequent thrombus formation. In accordance with these findings, platelet-derived high-mobility group box 1 protein can facilitate NET formation and coagulation (<xref rid="B51" ref-type="bibr">51</xref>). Similarly, Riegger et al. analyzed 253 samples from patients with stent thrombosis after percutaneous coronary intervention (<xref rid="B52" ref-type="bibr">52</xref>). Approximately 23% of the thrombi specimens contained NETs; however, no differences in the number of NETs were observed according to the timing of stent thrombosis, stent type, or in comparison with samples from patients with spontaneous myocardial infarction (<xref rid="B52" ref-type="bibr">52</xref>). Hence, recruitment of PMNs appears to be a hallmark of stent thrombosis.</p><p>As the main initiator of coagulation, with a critical role in arterial thrombosis, tissue factor (TF) has been investigated in patients with acute ST-segment-elevation myocardial infarction (<xref rid="B53" ref-type="bibr">53</xref>). Local accumulation of TF-bearing NETs is observed at sites of coronary thrombosis, and PMNs release NETs, thereby exposing TF in infarct-associated, but not non-infarcted, areas (<xref rid="B53" ref-type="bibr">53</xref>). In addition, neutrophil islets and NETs decorated with TF were detected in thrombi obtained from infarcted regions (<xref rid="B46" ref-type="bibr">46</xref>). Interactions between activated platelets and PMNs at sites of plaque rupture during acute myocardial infarction result in NET formation and delivery of active TF, which together foster thrombus formation. Notably, NETs were also identified as coated with IL-17, which promotes thrombosis by enhancing platelet aggregation in coronary thrombectomy samples (<xref rid="B48" ref-type="bibr">48</xref>). The role of NETs has also been examined in a model of myocardial ischemia&#x02013;reperfusion, and a significant cardioprotective effect of NET-inhibition treatment on myocardial ischemia&#x02013;reperfusion injury was clearly demonstrated (<xref rid="B54" ref-type="bibr">54</xref>).</p></sec><sec id="S6"><title>NETs and VTE</title><p>Deep venous thrombosis (DVT) and pulmonary embolism are designated &#x02018;VTE&#x02019; in the clinic. Venous thrombogenesis is usually accompanied by inflammatory reactions of ECs (<xref rid="B55" ref-type="bibr">55</xref>). As a key element of the inflammatory response, NETs also play an important role in venous thrombogenesis (Figure <xref ref-type="fig" rid="F1">1</xref>B). Unlike atherothrombosis, the onset of venous thrombosis is primarily initiated by endothelial injury, caused by disturbance of the blood stream or endothelial dysfunction, and mediated <italic>via</italic> damage-associated molecular patterns (<xref rid="B56" ref-type="bibr">56</xref>). Subsequently, Weibel&#x02013;Palade bodies derived from ECs secrete massive amounts of von Willebrand factor (vWF) and P-selectin, which adhere to platelets and recruit leukocytes (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>). NETs predominantly form during the organizing stage of human VTE development (<xref rid="B59" ref-type="bibr">59</xref>). At the local lesion site, platelets interact directly with PMNs and promote the production of NETs (<xref rid="B60" ref-type="bibr">60</xref>). Additionally, cytokines from activated ECs (e.g., IL-1&#x003b2;, IL-8, and ROS) can accelerate NET formation (<xref rid="B61" ref-type="bibr">61</xref>). NETs, in turn, induce EC activation through NET-derived proteases; for example, histones and defensins (<xref rid="B62" ref-type="bibr">62</xref>). Additionally, purified histones can enhance thrombin generation through both platelet-dependent and platelet-independent mechanisms; however, platelet aggregation in response to histone H3 is inhibited by ethylenediaminetetraacetic acid (EDTA), suggesting that platelet aggregation is caused by the positive charge of histones (<xref rid="B63" ref-type="bibr">63</xref>&#x02013;<xref rid="B65" ref-type="bibr">65</xref>). Intravenous administration of exogenous histones accelerates clot formation, whereas DNase treatment significantly delays the onset of DVT (<xref rid="B66" ref-type="bibr">66</xref>). In addition to clinical investigations, studies in mice have identified an association between the risk of DVT and high PMN counts, supporting an important and early role for NETs in venous thrombosis (<xref rid="B67" ref-type="bibr">67</xref>, <xref rid="B68" ref-type="bibr">68</xref>).</p><p>In the process of thrombosis propagation, circulating nucleosomes act as a platform for the degradation of tissue factor pathway inhibitor, which is mediated by NE (<xref rid="B69" ref-type="bibr">69</xref>). The levels of circulating nucleosomes in DVT patients are significantly elevated, and may be a useful plasma marker for NET formation (<xref rid="B70" ref-type="bibr">70</xref>). In addition to providing an adhesive platform for platelets, NETs also support the adhesion of red blood cells (<xref rid="B65" ref-type="bibr">65</xref>). NETs maintain the stability of thrombus <italic>via</italic> vWF, fibronectin, and fibrinogen; vWF and fibrinogen can interact with histones, and fibronectin has a DNA-binding domain (<xref rid="B71" ref-type="bibr">71</xref>). Heparin can remove histones, leading to the destabilization of NETs (<xref rid="B72" ref-type="bibr">72</xref>). <italic>In vitro</italic> data support the ability of NETs to stimulate the activation of coagulation cascades and platelet adhesion, and fibrin deposition colocalizes with NETs in blood clots (<xref rid="B69" ref-type="bibr">69</xref>). Purified histones impair thrombomodulin-dependent protein C activation to enhance plasma thrombin generation (<xref rid="B73" ref-type="bibr">73</xref>). Furthermore, DNA and histones interact with and trap platelets, most likely <italic>via</italic> electrostatic interactions or TLRs (<xref rid="B73" ref-type="bibr">73</xref>). Together, the findings described above indicate that NETs make a substantial contribution to maintenance of the stability of venous thrombi.</p><p>Monocytes are recruited during thrombosis and thrombolysis; however, the specific function of monocytes in dissolving NET-induced thrombus requires further investigation. NETs colocalize with fibrins and vWF in venous thrombi, and vWF and fibrins constitute the main scaffold that must be fragmented in order to destroy the integrity of the thrombus structure (Figure <xref ref-type="fig" rid="F1">1</xref>B) (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>). <italic>In vitro</italic>, NETs can provide a scaffold for clots to induce resistance to tPA-induced thrombolysis (<xref rid="B65" ref-type="bibr">65</xref>). DNase is a strong nuclease present in blood and has the power to degrade protein-free DNA; however, the ability of DNase to degrade NET-derived chromatin is limited, because their chromatin is decorated with numerous proteases and histones. Interestingly, DNase can cooperate with the plasminogen system during chromatin degradation (<xref rid="B74" ref-type="bibr">74</xref>). In addition, NETs may recruit plasminogen from the plasma. Histone H2B can serve as a receptor for plasminogen on the surface of human monocytes/macrophages and could potentially also serve this function in NETs (<xref rid="B75" ref-type="bibr">75</xref>). <italic>In vitro</italic> studies have shown that NET-derived NE and cathepsin G can degrade fibrin and enhance fibrinolysis in DVT (<xref rid="B76" ref-type="bibr">76</xref>). Plasma DNA concentrations correlate with D-dimer levels; therefore, it is plausible that circulating DNA may reflect the degradation of NETs within a thrombus (<xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B77" ref-type="bibr">77</xref>).</p><p>In immunothrombosis, NETs may function in capture of invasive pathogens, prevention of distant tissue involvement, concentration of pathogens for bactericidal killing, and recruitment of other immune cells to immune target sites (<xref rid="B78" ref-type="bibr">78</xref>). In models of sepsis, lipopolysaccharide can activate platelets and PMNs <italic>via</italic> TLR-4 to induce NETosis (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B79" ref-type="bibr">79</xref>). We have reported that PMNs from septic patients have significantly enhanced NET release, compared with those from healthy controls with increased risk of VTE (<xref rid="B80" ref-type="bibr">80</xref>). NET-associated immunothrombosis leads to more sturdy thrombi with reduced permeability and decreased susceptibility to thrombolysis, although this can be overcome with DNase treatment (<xref rid="B81" ref-type="bibr">81</xref>). In addition to sepsis, NETs and immunothrombosis have been implicated in other autoimmune diseases, including inflammatory bowel disease and vasculitis (<xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B83" ref-type="bibr">83</xref>).</p></sec><sec id="S7"><title>Future Challenges and Clinical Implications</title><p>Undoubtedly, more in-depth studies are needed to meticulously dissect the exact mechanisms of <italic>in vivo</italic> NET formation, and to clarify the importance of histone citrullination for NETosis (<xref rid="B84" ref-type="bibr">84</xref>). ROS generation by different types of leukocyte is a common trigger of NETosis; however, the exact mechanism of ROS-induced NETs formation and subsequent endothelial dysfunction is unclear (Figure <xref ref-type="fig" rid="F1">1</xref>). Moreover, how NET-derived proteases respond in atherosclerosis and thrombosis remains an open question. Movement from investigations of integrated NETs to study of more specific <italic>in vitro</italic> protease systems, which may better explain the phenomena associated with disease, is an interesting future prospect. NETs have been identified at each stage of cardiovascular disease. Nevertheless, whether NETs play different roles at different stages remains unknown. Additionally, it will be a challenge to explore whether NETs are involved in cross talk with smooth muscle cells, which are another major source of foam cells during atherosclerosis. Regarding DVT, it will be important to identify endogenous triggers of NET formation. Furthermore, whether the NETs involved in DVT are generated by cell lysis or a secretory process is another a critical question. A better understanding of NETosis, both with regards to structural constituents and context-specific functional decoration, will be a prerequisite to further elucidation of the role of NETs in atherosclerotic plaques and venous thrombus, and will be of paramount importance to the identification, validation, and implementation of the best molecular candidates for therapeutic targeting.</p><p>The notion that NETs represent a mechanism by which PMNs release thrombogenic signals during atherosclerosis and thrombosis may offer novel therapeutic targets (Table <xref ref-type="table" rid="T1">1</xref>). Thrombolysis has become a key weapon in the arsenal against pathologic thrombosis; however, not all thrombotic events are susceptible to thrombolysis. Indeed, the addition of DNA and histones to a fibrin matrix has been shown to generate artificial thrombus more resistant to tissue plasminogen activator, and which can be partially remedied by DNase (<xref rid="B85" ref-type="bibr">85</xref>). Preliminary data from murine models of DVT demonstrate inhibition of thrombus formation by DNase treatment prior to model establishment (<xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B67" ref-type="bibr">67</xref>). Although DNase treatment, which likely enhances thrombolysis, appears to harbor relevant therapeutic potential, its utility and applicability to prevention of NET formation or digestion of established NETs to reduce atherosclerotic lesion growth is debatable and will remain controversial (<xref rid="B86" ref-type="bibr">86</xref>). Moreover, knockout of neutrophil oxidase 2, a NET component, can result in accelerating disease in a murine model of lupus; therefore, caution is required in the selection of NET-associated molecular targets. Another potential target is NET-related platelet recruitment to the endothelium (<xref rid="B37" ref-type="bibr">37</xref>). Specifically, blockade of platelet alpha-granule or endothelial Weibel&#x02013;Palade body release would decrease P-selectin- and vWF-mediated platelet and PMN recruitment to the endothelium, thereby decreasing NETosis (<xref rid="B87" ref-type="bibr">87</xref>). Similarly, vWF degradation enzyme could be administered to prevent PMN recruitment with subsequent NETosis (<xref rid="B88" ref-type="bibr">88</xref>). Although these countermeasures may result in mild immunodeficiency, they could also abrogate pathologic immune-mediated thrombosis without sacrificing immune competence when administered in a controlled manner. It is noteworthy that NETs are not major role players in these diseases but may definitely exacerbate the condition and therapies may have to be combinatorial because NET formation is only one of the factors.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Potential targets for translation in the prevention of NET-mediated atherosclerosis and thrombosis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="2" colspan="1">Diseases</th><th valign="top" align="left" rowspan="2" colspan="1">Target</th><th valign="top" align="left" rowspan="2" colspan="1">Function</th><th valign="top" align="center" colspan="2" rowspan="1">Clinical implications<hr/></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">Clinical therapies</th><th valign="top" align="left" rowspan="1" colspan="1">Potential treatment</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="6" colspan="1">Atherosclerosis</td><td align="left" valign="top" rowspan="1" colspan="1">cfDNA</td><td align="left" valign="top" rowspan="1" colspan="1">Stimulation of plasmacytoid dendritic cells</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Deoxyribonuclease (<xref rid="B86" ref-type="bibr">86</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MPO</td><td align="left" valign="top" rowspan="1" colspan="1">Induction of ROS</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Ocimum tenuiflorum (<xref rid="B89" ref-type="bibr">89</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cathepsin G</td><td align="left" valign="top" rowspan="1" colspan="1">Attraction of monocyte</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Ac-Phe-Val-Thr-(4-guanidine)-Phg(P)-(OPh4-SMe)2 (<xref rid="B90" ref-type="bibr">90</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cathelicidins</td><td align="left" valign="top" rowspan="1" colspan="1">Attraction of monocyte</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL17</td><td align="left" valign="top" rowspan="1" colspan="1">Amplification of platelet aggregation</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-1&#x003b2;</td><td align="left" valign="top" rowspan="1" colspan="1">Amplification of inflammatory reaction; stimulation to Th17&#x02009;cells</td><td align="left" valign="top" rowspan="1" colspan="1">Rimonabant (<xref rid="B91" ref-type="bibr">91</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="10" colspan="1">Venous thromboembolism</td><td align="left" valign="top" rowspan="1" colspan="1">Histones</td><td align="left" valign="top" rowspan="1" colspan="1">Endothelial injury</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Activated protein C (<xref rid="B62" ref-type="bibr">62</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NE</td><td align="left" valign="top" rowspan="1" colspan="1">Degradation of TFPI and fibrin</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Leu89 with alanine (<xref rid="B69" ref-type="bibr">69</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cathepsin G</td><td align="left" valign="top" rowspan="1" colspan="1">Degradation of fibrin and enhancement of fibrinolysis</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Leu89 with alanine (<xref rid="B69" ref-type="bibr">69</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P-selectin</td><td align="left" valign="top" rowspan="1" colspan="1">Adherence to platelet</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Anti-P-selectin aptamer; anti-P-selectin glycoprotein ligand-1 inhibitory antibody (<xref rid="B58" ref-type="bibr">58</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">vWF</td><td align="left" valign="top" rowspan="1" colspan="1">Adherence to platelet</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Anti-P-selectin glycoprotein ligand-1 inhibitory antibody (<xref rid="B92" ref-type="bibr">92</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TF</td><td align="left" valign="top" rowspan="1" colspan="1">Activation of coagulation cascade</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">TFPI (<xref rid="B93" ref-type="bibr">93</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AT</td><td align="left" valign="top" rowspan="1" colspan="1">Anticoagulation</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">APC</td><td align="left" valign="top" rowspan="1" colspan="1">anticoagulation</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Thrombin</td><td align="left" valign="top" rowspan="1" colspan="1">Promotion of coagulation</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">PAR-1 antagonists (<xref rid="B94" ref-type="bibr">94</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fibrin</td><td align="left" valign="top" rowspan="1" colspan="1">Promotion of coagulation</td><td align="left" valign="top" rowspan="1" colspan="1">Urokinase; rtPA</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><italic>Antimicrobial proteins (<xref rid="B1" ref-type="bibr">1</xref>)</italic>.</p><p><italic>NETs, neutrophil extracelluar traps; cfDNA, cell-free DNA; MPO, myeloperoxidase; ROS, reactive oxygen species; IL-17, interleukin 17; IL-1&#x003b2;, interleukin 1&#x003b2;; NE, neutrophil elastase; TFPI, tissue factor pathway inhibitor; vWF, von-Willebrand factor; TF, tissue factor; AT, antithrombin; PAR, proteinase-activated receptor; APC, activated protein C; rtPA, recombinant tissue plasminogen activator</italic>.</p></table-wrap-foot></table-wrap></sec><sec id="S8"><title>Conclusion</title><p>Neutrophil extracellular trap-structure is an important novel discovery that has potential to influence our understanding of cardiovascular disease. Functionally, NETs can induce activation of ECs, antigen-presenting cells, and platelets, and cause endothelial dysfunction, resulting in a proinflammatory immune response. As evidenced by the results of the studies discussed above, NETs can clearly contribute to the initiation and progression of atherosclerotic and thrombotic lesions. Moreover, there is evidence for an emerging role of PMNs, focused on NETosis and oxidative stress burden, in orchestrating common mechanisms involved in various forms of cardiovascular disease. Extensive future research will be required to determine the effects of NETs in endothelial dysfunction-induced cardiovascular disease; hence, the time is not yet ideal to implement therapeutic options targeting neutrophils in the context of atherosclerosis and thrombosis.</p></sec><sec id="S9"><title>Author Contributions</title><p>HQ contributed to the conception of the study, consulting literatures, and manuscript preparation; SY make the figure and modify the manuscript; LZ helped perform the analysis with constructive discussions.</p></sec><sec id="S10"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>All authors critically revised the review for intellectual content and approved the final version.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by the National Natural Science Foundation of China grants (#81670442 to LZ).</p></fn></fn-group><sec id="S11"><title>Abbreviations</title><p>NETs, neutrophil extracellular traps; PMN, polymorphonuclear neutrophil; DNase, deoxyribonuclease; ECs, endothelial cells; VTE, venous thromboembolism; TLR, toll-like receptor; ROS, reactive oxygen species; NE, neutrophil elastase; PAD4, peptidyl arginine deiminase 4; G-CSF, granulocyte colony-stimulating factor; MPO, myeloperoxidase; IL, interleukin; CXCL, C-X-C motif ligand; LDL, low-density lipoprotein; DVT, deep venous thrombosis; PE, pulmonary embolism; vWF, von Willebrand factor; EDTA, ethylenediamine-tetraacetic acid.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>TA</given-names></name><name><surname>Abed</surname><given-names>U</given-names></name><name><surname>Goosmann</surname><given-names>C</given-names></name><name><surname>Hurwitz</surname><given-names>R</given-names></name><name><surname>Schulze</surname><given-names>I</given-names></name><name><surname>Wahn</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Novel cell death program leads to neutrophil extracellular traps</article-title>. <source>J Cell Biol</source> (<year>2007</year>) <volume>176</volume>:<fpage>231</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1083/jcb.200606027</pub-id><?supplied-pmid 17210947?><pub-id pub-id-type="pmid">17210947</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinkmann</surname><given-names>V</given-names></name><name><surname>Reichard</surname><given-names>U</given-names></name><name><surname>Goosmann</surname><given-names>C</given-names></name><name><surname>Fauler</surname><given-names>B</given-names></name><name><surname>Uhlemann</surname><given-names>Y</given-names></name><name><surname>Weiss</surname><given-names>DS</given-names></name><etal/></person-group>
<article-title>Neutrophil extracellular traps kill bacteria</article-title>. <source>Science</source> (<year>2004</year>) <volume>303</volume>:<fpage>1532</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1126/science.1092385</pub-id><?supplied-pmid 15001782?><pub-id pub-id-type="pmid">15001782</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorensen</surname><given-names>OE</given-names></name><name><surname>Borregaard</surname><given-names>N</given-names></name></person-group>
<article-title>Neutrophil extracellular traps &#x02013; the dark side of neutrophils</article-title>. <source>J Clin Invest</source> (<year>2016</year>) <volume>126</volume>:<fpage>1612</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1172/JCI84538</pub-id><pub-id pub-id-type="pmid">27135878</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>GD</given-names></name></person-group>. <article-title>Common risk factors for both arterial and venous thrombosis</article-title>. <source>Br J Haematol</source> (<year>2008</year>) <volume>140</volume>:<fpage>488</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2141.2007.06973.x</pub-id><?supplied-pmid 18275426?><pub-id pub-id-type="pmid">18275426</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorch</surname><given-names>SK</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group>. <article-title>An emerging role for neutrophil extracellular traps in noninfectious disease</article-title>. <source>Nat Med</source> (<year>2017</year>) <volume>23</volume>:<fpage>279</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1038/nm.4294</pub-id><?supplied-pmid 28267716?><pub-id pub-id-type="pmid">28267716</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Pelayo</surname><given-names>R</given-names></name><name><surname>Monestier</surname><given-names>M</given-names></name><name><surname>Ammollo</surname><given-names>CT</given-names></name><name><surname>Semeraro</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Extracellular histones are major mediators of death in sepsis</article-title>. <source>Nat Med</source> (<year>2009</year>) <volume>15</volume>:<fpage>1318</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1038/nm.2053</pub-id><?supplied-pmid 19855397?><pub-id pub-id-type="pmid">19855397</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yipp</surname><given-names>BG</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group>. <article-title>NETosis: how vital is it?</article-title>
<source>Blood</source> (<year>2013</year>) <volume>122</volume>:<fpage>2784</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2013-04-457671</pub-id><?supplied-pmid 24009232?><pub-id pub-id-type="pmid">24009232</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doring</surname><given-names>Y</given-names></name><name><surname>Soehnlein</surname><given-names>O</given-names></name><name><surname>Weber</surname><given-names>C</given-names></name></person-group>. <article-title>Neutrophil extracellular traps in atherosclerosis and atherothrombosis</article-title>. <source>Circ Res</source> (<year>2017</year>) <volume>120</volume>:<fpage>736</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.309692</pub-id><?supplied-pmid 28209798?><pub-id pub-id-type="pmid">28209798</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Buhr</surname><given-names>N</given-names></name><name><surname>von Kockritz-Blickwede</surname><given-names>M</given-names></name></person-group>. <article-title>How neutrophil extracellular traps become visible</article-title>. <source>J Immunol Res</source> (<year>2016</year>) <volume>2016</volume>:<fpage>4604713</fpage>.<pub-id pub-id-type="doi">10.1155/2016/4604713</pub-id><?supplied-pmid 27294157?><pub-id pub-id-type="pmid">27294157</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Fogg</surname><given-names>DK</given-names></name><name><surname>Kaplan</surname><given-names>MJ</given-names></name></person-group>. <article-title>A novel image-based quantitative method for the characterization of NETosis</article-title>. <source>J Immunol Methods</source> (<year>2015</year>) <volume>423</volume>:<fpage>104</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1016/j.jim.2015.04.027</pub-id><?supplied-pmid 26003624?><pub-id pub-id-type="pmid">26003624</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delgado-Rizo</surname><given-names>V</given-names></name><name><surname>Martinez-Guzman</surname><given-names>MA</given-names></name><name><surname>Iniguez-Gutierrez</surname><given-names>L</given-names></name><name><surname>Garcia-Orozco</surname><given-names>A</given-names></name><name><surname>Alvarado-Navarro</surname><given-names>A</given-names></name><name><surname>Fafutis-Morris</surname><given-names>M</given-names></name></person-group>. <article-title>Neutrophil extracellular traps and its implications in inflammation: an overview</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<fpage>81</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2017.00081</pub-id><?supplied-pmid 28220120?><pub-id pub-id-type="pmid">28220120</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilsczek</surname><given-names>FH</given-names></name><name><surname>Salina</surname><given-names>D</given-names></name><name><surname>Poon</surname><given-names>KK</given-names></name><name><surname>Fahey</surname><given-names>C</given-names></name><name><surname>Yipp</surname><given-names>BG</given-names></name><name><surname>Sibley</surname><given-names>CD</given-names></name><etal/></person-group>
<article-title>A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to <italic>Staphylococcus aureus</italic></article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>185</volume>:<fpage>7413</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1000675</pub-id><?supplied-pmid 21098229?><pub-id pub-id-type="pmid">21098229</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>A</given-names></name><name><surname>Dahlgren</surname><given-names>C</given-names></name></person-group>. <article-title>Assembly and activation of the neutrophil NADPH oxidase in granule membranes</article-title>. <source>Antioxid Redox Signal</source> (<year>2002</year>) <volume>4</volume>:<fpage>49</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1089/152308602753625852</pub-id><?supplied-pmid 11970843?><pub-id pub-id-type="pmid">11970843</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papayannopoulos</surname><given-names>V</given-names></name><name><surname>Metzler</surname><given-names>KD</given-names></name><name><surname>Hakkim</surname><given-names>A</given-names></name><name><surname>Zychlinsky</surname><given-names>A</given-names></name></person-group>. <article-title>Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps</article-title>. <source>J Cell Biol</source> (<year>2010</year>) <volume>191</volume>:<fpage>677</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1083/jcb.201006052</pub-id><?supplied-pmid 20974816?><pub-id pub-id-type="pmid">20974816</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousefi</surname><given-names>S</given-names></name><name><surname>Mihalache</surname><given-names>C</given-names></name><name><surname>Kozlowski</surname><given-names>E</given-names></name><name><surname>Schmid</surname><given-names>I</given-names></name><name><surname>Simon</surname><given-names>HU</given-names></name></person-group>. <article-title>Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps</article-title>. <source>Cell Death Differ</source> (<year>2009</year>) <volume>16</volume>:<fpage>1438</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1038/cdd.2009.96</pub-id><?supplied-pmid 19609275?><pub-id pub-id-type="pmid">19609275</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papayannopoulos</surname><given-names>V</given-names></name><name><surname>Zychlinsky</surname><given-names>A</given-names></name></person-group>. <article-title>NETs: a new strategy for using old weapons</article-title>. <source>Trends Immunol</source> (<year>2009</year>) <volume>30</volume>:<fpage>513</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2009.07.011</pub-id><?supplied-pmid 19699684?><pub-id pub-id-type="pmid">19699684</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urban</surname><given-names>CF</given-names></name><name><surname>Ermert</surname><given-names>D</given-names></name><name><surname>Schmid</surname><given-names>M</given-names></name><name><surname>Abu-Abed</surname><given-names>U</given-names></name><name><surname>Goosmann</surname><given-names>C</given-names></name><name><surname>Nacken</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against <italic>Candida albicans</italic></article-title>. <source>PLoS Pathog</source> (<year>2009</year>) <volume>5</volume>:<fpage>e1000639</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1000639</pub-id><?supplied-pmid 19876394?><pub-id pub-id-type="pmid">19876394</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Stadler</surname><given-names>S</given-names></name><name><surname>Correll</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation</article-title>. <source>J Cell Biol</source> (<year>2009</year>) <volume>184</volume>:<fpage>205</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1083/jcb.200806072</pub-id><?supplied-pmid 19153223?><pub-id pub-id-type="pmid">19153223</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>. <article-title>Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis</article-title>. <source>Biochim Biophys Acta</source> (<year>2013</year>) <volume>1829</volume>:<fpage>1126</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbagrm.2013.07.003</pub-id><?supplied-pmid 23860259?><pub-id pub-id-type="pmid">23860259</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Lindberg</surname><given-names>MR</given-names></name><name><surname>Kennett</surname><given-names>MJ</given-names></name><name><surname>Xiong</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>. <article-title>PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps</article-title>. <source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>:<fpage>1853</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20100239</pub-id><?supplied-pmid 20733033?><pub-id pub-id-type="pmid">20733033</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zabieglo</surname><given-names>K</given-names></name><name><surname>Majewski</surname><given-names>P</given-names></name><name><surname>Majchrzak-Gorecka</surname><given-names>M</given-names></name><name><surname>Wlodarczyk</surname><given-names>A</given-names></name><name><surname>Grygier</surname><given-names>B</given-names></name><name><surname>Zegar</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps</article-title>. <source>J Leukoc Biol</source> (<year>2015</year>) <volume>98</volume>:<fpage>99</fpage>&#x02013;<lpage>106</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.4AB1114-543R</pub-id><?supplied-pmid 25917460?><pub-id pub-id-type="pmid">25917460</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossaint</surname><given-names>J</given-names></name><name><surname>Herter</surname><given-names>JM</given-names></name><name><surname>Van Aken</surname><given-names>H</given-names></name><name><surname>Napirei</surname><given-names>M</given-names></name><name><surname>Doring</surname><given-names>Y</given-names></name><name><surname>Weber</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation</article-title>. <source>Blood</source> (<year>2014</year>) <volume>123</volume>:<fpage>2573</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2013-07-516484</pub-id><?supplied-pmid 24335230?><pub-id pub-id-type="pmid">24335230</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansson</surname><given-names>GK</given-names></name><name><surname>Hermansson</surname><given-names>A</given-names></name></person-group>. <article-title>The immune system in atherosclerosis</article-title>. <source>Nat Immunol</source> (<year>2011</year>) <volume>12</volume>:<fpage>204</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2001</pub-id><?supplied-pmid 21321594?><pub-id pub-id-type="pmid">21321594</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drechsler</surname><given-names>M</given-names></name><name><surname>Megens</surname><given-names>RT</given-names></name><name><surname>van Zandvoort</surname><given-names>M</given-names></name><name><surname>Weber</surname><given-names>C</given-names></name><name><surname>Soehnlein</surname><given-names>O</given-names></name></person-group>. <article-title>Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis</article-title>. <source>Circulation</source> (<year>2010</year>) <volume>122</volume>:<fpage>1837</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.961714</pub-id><?supplied-pmid 20956207?><pub-id pub-id-type="pmid">20956207</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galligan</surname><given-names>C</given-names></name><name><surname>Yoshimura</surname><given-names>T</given-names></name></person-group>
<article-title>Phenotypic and functional changes of cytokine-activated neutrophils</article-title>. <source>Chem Immunol Allergy</source> (<year>2003</year>) <volume>83</volume>:<fpage>24</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1159/000071555</pub-id><pub-id pub-id-type="pmid">12947977</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname><given-names>MA</given-names></name><name><surname>Huo</surname><given-names>Y</given-names></name><name><surname>Burcin</surname><given-names>TL</given-names></name><name><surname>Morris</surname><given-names>MA</given-names></name><name><surname>Olson</surname><given-names>TS</given-names></name><name><surname>Ley</surname><given-names>K</given-names></name></person-group>. <article-title>Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17</article-title>. <source>Immunity</source> (<year>2005</year>) <volume>22</volume>:<fpage>285</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2005.01.011</pub-id><?supplied-pmid 15780986?><pub-id pub-id-type="pmid">15780986</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christopher</surname><given-names>MJ</given-names></name><name><surname>Link</surname><given-names>DC</given-names></name></person-group>. <article-title>Regulation of neutrophil homeostasis</article-title>. <source>Curr Opin Hematol</source> (<year>2007</year>) <volume>14</volume>:<fpage>3</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1097/00062752-200701000-00003</pub-id><?supplied-pmid 17133093?><pub-id pub-id-type="pmid">17133093</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eash</surname><given-names>KJ</given-names></name><name><surname>Greenbaum</surname><given-names>AM</given-names></name><name><surname>Gopalan</surname><given-names>PK</given-names></name><name><surname>Link</surname><given-names>DC</given-names></name></person-group>. <article-title>CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow</article-title>. <source>J Clin Invest</source> (<year>2010</year>) <volume>120</volume>:<fpage>2423</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1172/jci41649</pub-id><?supplied-pmid 20516641?><pub-id pub-id-type="pmid">20516641</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kougias</surname><given-names>P</given-names></name><name><surname>Chai</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>PH</given-names></name><name><surname>Yao</surname><given-names>Q</given-names></name><name><surname>Lumsden</surname><given-names>AB</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name></person-group>. <article-title>Defensins and cathelicidins: neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis</article-title>. <source>J Cell Mol Med</source> (<year>2005</year>) <volume>9</volume>:<fpage>3</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1111/j.1582-4934.2005.tb00332.x</pub-id><?supplied-pmid 15784160?><pub-id pub-id-type="pmid">15784160</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Sjoberg</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>TT</given-names></name><name><surname>Oorni</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Cathepsin G activity lowers plasma LDL and reduces atherosclerosis</article-title>. <source>Biochim Biophys Acta</source> (<year>2014</year>) <volume>1842</volume>:<fpage>2174</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbadis.2014.07.026</pub-id><?supplied-pmid 25092171?><pub-id pub-id-type="pmid">25092171</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soehnlein</surname><given-names>O</given-names></name><name><surname>Zernecke</surname><given-names>A</given-names></name><name><surname>Eriksson</surname><given-names>EE</given-names></name><name><surname>Rothfuchs</surname><given-names>AG</given-names></name><name><surname>Pham</surname><given-names>CT</given-names></name><name><surname>Herwald</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Neutrophil secretion products pave the way for inflammatory monocytes</article-title>. <source>Blood</source> (<year>2008</year>) <volume>112</volume>:<fpage>1461</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2008-02-139634</pub-id><?supplied-pmid 18490516?><pub-id pub-id-type="pmid">18490516</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doring</surname><given-names>Y</given-names></name><name><surname>Drechsler</surname><given-names>M</given-names></name><name><surname>Wantha</surname><given-names>S</given-names></name><name><surname>Kemmerich</surname><given-names>K</given-names></name><name><surname>Lievens</surname><given-names>D</given-names></name><name><surname>Vijayan</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice</article-title>. <source>Circ Res</source> (<year>2012</year>) <volume>110</volume>:<fpage>1052</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1161/circresaha.112.265868</pub-id><?supplied-pmid 22394519?><pub-id pub-id-type="pmid">22394519</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wantha</surname><given-names>S</given-names></name><name><surname>Alard</surname><given-names>JE</given-names></name><name><surname>Megens</surname><given-names>RT</given-names></name><name><surname>van der Does</surname><given-names>AM</given-names></name><name><surname>Doring</surname><given-names>Y</given-names></name><name><surname>Drechsler</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Neutrophil-derived cathelicidin promotes adhesion of classical monocytes</article-title>. <source>Circ Res</source> (<year>2013</year>) <volume>112</volume>:<fpage>792</fpage>&#x02013;<lpage>801</lpage>.<pub-id pub-id-type="doi">10.1161/circresaha.112.300666</pub-id><?supplied-pmid 23283724?><pub-id pub-id-type="pmid">23283724</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname><given-names>F</given-names></name><name><surname>Mach</surname><given-names>F</given-names></name><name><surname>Montecucco</surname><given-names>F</given-names></name></person-group>. <article-title>Update on the role of neutrophils in atherosclerotic plaque vulnerability</article-title>. <source>Curr Drug Targets</source> (<year>2015</year>) <volume>16</volume>:<fpage>321</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.2174/1389450115666141110093013</pub-id><?supplied-pmid 25382205?><pub-id pub-id-type="pmid">25382205</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chistiakov</surname><given-names>DA</given-names></name><name><surname>Bobryshev</surname><given-names>YV</given-names></name><name><surname>Orekhov</surname><given-names>AN</given-names></name></person-group>. <article-title>Neutrophil&#x02019;s weapons in atherosclerosis</article-title>. <source>Exp Mol Pathol</source> (<year>2015</year>) <volume>99</volume>:<fpage>663</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1016/j.yexmp.2015.11.011</pub-id><?supplied-pmid 26551083?><pub-id pub-id-type="pmid">26551083</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warnatsch</surname><given-names>A</given-names></name><name><surname>Ioannou</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Papayannopoulos</surname><given-names>V</given-names></name></person-group>. <article-title>Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis</article-title>. <source>Science</source> (<year>2015</year>) <volume>349</volume>:<fpage>316</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1126/science.aaa8064</pub-id><?supplied-pmid 26185250?><pub-id pub-id-type="pmid">26185250</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>JS</given-names></name><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>O&#x02019;Dell</surname><given-names>AA</given-names></name><name><surname>Yalavarthi</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Subramanian</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis</article-title>. <source>Circ Res</source> (<year>2014</year>) <volume>114</volume>:<fpage>947</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.114.303312</pub-id><?supplied-pmid 24425713?><pub-id pub-id-type="pmid">24425713</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doring</surname><given-names>Y</given-names></name><name><surname>Manthey</surname><given-names>HD</given-names></name><name><surname>Drechsler</surname><given-names>M</given-names></name><name><surname>Lievens</surname><given-names>D</given-names></name><name><surname>Megens</surname><given-names>RT</given-names></name><name><surname>Soehnlein</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis</article-title>. <source>Circulation</source> (<year>2012</year>) <volume>125</volume>:<fpage>1673</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.046755</pub-id><?supplied-pmid 22388324?><pub-id pub-id-type="pmid">22388324</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macritchie</surname><given-names>N</given-names></name><name><surname>Grassia</surname><given-names>G</given-names></name><name><surname>Sabir</surname><given-names>SR</given-names></name><name><surname>Maddaluno</surname><given-names>M</given-names></name><name><surname>Welsh</surname><given-names>P</given-names></name><name><surname>Sattar</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2012</year>) <volume>32</volume>:<fpage>2569</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="doi">10.1161/ATVBAHA.112.251314</pub-id><?supplied-pmid 22936340?><pub-id pub-id-type="pmid">22936340</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libby</surname><given-names>P</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Hansson</surname><given-names>GK</given-names></name></person-group>. <article-title>Progress and challenges in translating the biology of atherosclerosis</article-title>. <source>Nature</source> (<year>2011</year>) <volume>473</volume>:<fpage>317</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1038/nature10146</pub-id><?supplied-pmid 21593864?><pub-id pub-id-type="pmid">21593864</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horne</surname><given-names>BD</given-names></name><name><surname>Anderson</surname><given-names>JL</given-names></name><name><surname>John</surname><given-names>JM</given-names></name><name><surname>Weaver</surname><given-names>A</given-names></name><name><surname>Bair</surname><given-names>TL</given-names></name><name><surname>Jensen</surname><given-names>KR</given-names></name><etal/></person-group>
<article-title>Which white blood cell subtypes predict increased cardiovascular risk?</article-title>
<source>J Am Coll Cardiol</source> (<year>2005</year>) <volume>45</volume>:<fpage>1638</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1016/j.jacc.2005.02.054</pub-id><?supplied-pmid 15893180?><pub-id pub-id-type="pmid">15893180</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Distelmaier</surname><given-names>K</given-names></name><name><surname>Adlbrecht</surname><given-names>C</given-names></name><name><surname>Jakowitsch</surname><given-names>J</given-names></name><name><surname>Winkler</surname><given-names>S</given-names></name><name><surname>Dunkler</surname><given-names>D</given-names></name><name><surname>Gerner</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction</article-title>. <source>Thromb Haemost</source> (<year>2009</year>) <volume>102</volume>:<fpage>564</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1160/th09-02-0103</pub-id><?supplied-pmid 19718478?><pub-id pub-id-type="pmid">19718478</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramaiola</surname><given-names>I</given-names></name><name><surname>Padro</surname><given-names>T</given-names></name><name><surname>Pena</surname><given-names>E</given-names></name><name><surname>Juan-Babot</surname><given-names>O</given-names></name><name><surname>Cubedo</surname><given-names>J</given-names></name><name><surname>Martin-Yuste</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Changes in thrombus composition and profilin-1 release in acute myocardial infarction</article-title>. <source>Eur Heart J</source> (<year>2015</year>) <volume>36</volume>:<fpage>965</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1093/eurheartj/ehu356</pub-id><?supplied-pmid 25217443?><pub-id pub-id-type="pmid">25217443</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yunoki</surname><given-names>K</given-names></name><name><surname>Naruko</surname><given-names>T</given-names></name><name><surname>Sugioka</surname><given-names>K</given-names></name><name><surname>Inaba</surname><given-names>M</given-names></name><name><surname>Iwasa</surname><given-names>Y</given-names></name><name><surname>Komatsu</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Erythrocyte-rich thrombus aspirated from patients with ST-elevation myocardial infarction: association with oxidative stress and its impact on myocardial reperfusion</article-title>. <source>Eur Heart J</source> (<year>2012</year>) <volume>33</volume>:<fpage>1480</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1093/eurheartj/ehr486</pub-id><?supplied-pmid 22240493?><pub-id pub-id-type="pmid">22240493</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silvain</surname><given-names>J</given-names></name><name><surname>Collet</surname><given-names>JP</given-names></name><name><surname>Nagaswami</surname><given-names>C</given-names></name><name><surname>Beygui</surname><given-names>F</given-names></name><name><surname>Edmondson</surname><given-names>KE</given-names></name><name><surname>Bellemain-Appaix</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Composition of coronary thrombus in acute myocardial infarction</article-title>. <source>J Am Coll Cardiol</source> (<year>2011</year>) <volume>57</volume>:<fpage>1359</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1016/j.jacc.2010.09.077</pub-id><?supplied-pmid 21414532?><pub-id pub-id-type="pmid">21414532</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stakos</surname><given-names>DA</given-names></name><name><surname>Kambas</surname><given-names>K</given-names></name><name><surname>Konstantinidis</surname><given-names>T</given-names></name><name><surname>Mitroulis</surname><given-names>I</given-names></name><name><surname>Apostolidou</surname><given-names>E</given-names></name><name><surname>Arelaki</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction</article-title>. <source>Eur Heart J</source> (<year>2015</year>) <volume>36</volume>:<fpage>1405</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1093/eurheartj/ehv007</pub-id><?supplied-pmid 25660055?><pub-id pub-id-type="pmid">25660055</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borissoff</surname><given-names>JI</given-names></name><name><surname>Joosen</surname><given-names>IA</given-names></name><name><surname>Versteylen</surname><given-names>MO</given-names></name><name><surname>Brill</surname><given-names>A</given-names></name><name><surname>Fuchs</surname><given-names>TA</given-names></name><name><surname>Savchenko</surname><given-names>AS</given-names></name><etal/></person-group>
<article-title>Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2013</year>) <volume>33</volume>:<fpage>2032</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1161/ATVBAHA.113.301627</pub-id><?supplied-pmid 23818485?><pub-id pub-id-type="pmid">23818485</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Boer</surname><given-names>OJ</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Teeling</surname><given-names>P</given-names></name><name><surname>Mackaay</surname><given-names>C</given-names></name><name><surname>Ploegmakers</surname><given-names>HJ</given-names></name><name><surname>van der Loos</surname><given-names>CM</given-names></name><etal/></person-group>
<article-title>Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction</article-title>. <source>Thromb Haemost</source> (<year>2013</year>) <volume>109</volume>:<fpage>290</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1160/TH12-06-0425</pub-id><?supplied-pmid 23238559?><pub-id pub-id-type="pmid">23238559</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangold</surname><given-names>A</given-names></name><name><surname>Alias</surname><given-names>S</given-names></name><name><surname>Scherz</surname><given-names>T</given-names></name><name><surname>Hofbauer</surname><given-names>T</given-names></name><name><surname>Jakowitsch</surname><given-names>J</given-names></name><name><surname>Panzenbock</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size</article-title>. <source>Circ Res</source> (<year>2015</year>) <volume>116</volume>:<fpage>1182</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.304944</pub-id><?supplied-pmid 25547404?><pub-id pub-id-type="pmid">25547404</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maugeri</surname><given-names>N</given-names></name><name><surname>Campana</surname><given-names>L</given-names></name><name><surname>Gavina</surname><given-names>M</given-names></name><name><surname>Covino</surname><given-names>C</given-names></name><name><surname>De Metrio</surname><given-names>M</given-names></name><name><surname>Panciroli</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps</article-title>. <source>J Thromb Haemost</source> (<year>2014</year>) <volume>12</volume>:<fpage>2074</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1111/jth.12710</pub-id><?supplied-pmid 25163512?><pub-id pub-id-type="pmid">25163512</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname><given-names>K</given-names></name><name><surname>Philippi</surname><given-names>V</given-names></name><name><surname>Stockhausen</surname><given-names>S</given-names></name><name><surname>Busse</surname><given-names>J</given-names></name><name><surname>Antonelli</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice</article-title>. <source>Blood</source> (<year>2016</year>) <volume>128</volume>:<fpage>2435</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2016-04-710632</pub-id><?supplied-pmid 27574188?><pub-id pub-id-type="pmid">27574188</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riegger</surname><given-names>J</given-names></name><name><surname>Byrne</surname><given-names>RA</given-names></name><name><surname>Joner</surname><given-names>M</given-names></name><name><surname>Chandraratne</surname><given-names>S</given-names></name><name><surname>Gershlick</surname><given-names>AH</given-names></name><name><surname>Ten Berg</surname><given-names>JM</given-names></name><etal/></person-group>
<article-title>Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium</article-title>. <source>Eur Heart J</source> (<year>2016</year>) <volume>37</volume>:<fpage>1538</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1093/eurheartj/ehv419</pub-id><?supplied-pmid 26761950?><pub-id pub-id-type="pmid">26761950</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darbousset</surname><given-names>R</given-names></name><name><surname>Thomas</surname><given-names>GM</given-names></name><name><surname>Mezouar</surname><given-names>S</given-names></name><name><surname>Frere</surname><given-names>C</given-names></name><name><surname>Bonier</surname><given-names>R</given-names></name><name><surname>Mackman</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation</article-title>. <source>Blood</source> (<year>2012</year>) <volume>120</volume>:<fpage>2133</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2012-06-437772</pub-id><?supplied-pmid 22837532?><pub-id pub-id-type="pmid">22837532</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savchenko</surname><given-names>AS</given-names></name><name><surname>Borissoff</surname><given-names>JI</given-names></name><name><surname>Martinod</surname><given-names>K</given-names></name><name><surname>De Meyer</surname><given-names>SF</given-names></name><name><surname>Gallant</surname><given-names>M</given-names></name><name><surname>Erpenbeck</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice</article-title>. <source>Blood</source> (<year>2014</year>) <volume>123</volume>:<fpage>141</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2013-07-514992</pub-id><?supplied-pmid 24200682?><pub-id pub-id-type="pmid">24200682</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Nisio</surname><given-names>M</given-names></name><name><surname>van Es</surname><given-names>N</given-names></name><name><surname>Buller</surname><given-names>HR</given-names></name></person-group>
<article-title>Deep vein thrombosis and pulmonary embolism</article-title>. <source>Lancet</source> (<year>2016</year>) <volume>388</volume>:<fpage>3060</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(16)30514-1</pub-id><pub-id pub-id-type="pmid">27375038</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>LaPenna</surname><given-names>KB</given-names></name><name><surname>Yokota</surname><given-names>SD</given-names></name><name><surname>Huke</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>P</given-names></name></person-group>
<article-title>New insights into shear stress-induced endothelial signaling and barrier function: cell-free fluid verses blood flow</article-title>. <source>Cardiovasc Res</source> (<year>2017</year>) <volume>113</volume>(<issue>5</issue>):<fpage>508</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="doi">10.1093/cvr/cvx021</pub-id><pub-id pub-id-type="pmid">28158679</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michels</surname><given-names>A</given-names></name><name><surname>Albanez</surname><given-names>S</given-names></name><name><surname>Mewburn</surname><given-names>J</given-names></name><name><surname>Nesbitt</surname><given-names>K</given-names></name><name><surname>Gould</surname><given-names>TJ</given-names></name><name><surname>Liaw</surname><given-names>PC</given-names></name><etal/></person-group>
<article-title>Histones link inflammation and thrombosis through the induction of Weibel-Palade body exocytosis</article-title>. <source>J Thromb Haemost</source> (<year>2016</year>) <volume>14</volume>:<fpage>2274</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1111/jth.13493</pub-id><?supplied-pmid 27589692?><pub-id pub-id-type="pmid">27589692</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etulain</surname><given-names>J</given-names></name><name><surname>Martinod</surname><given-names>K</given-names></name><name><surname>Wong</surname><given-names>SL</given-names></name><name><surname>Cifuni</surname><given-names>SM</given-names></name><name><surname>Schattner</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>DD</given-names></name></person-group>. <article-title>P-selectin promotes neutrophil extracellular trap formation in mice</article-title>. <source>Blood</source> (<year>2015</year>) <volume>126</volume>:<fpage>242</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2015-01-624023</pub-id><?supplied-pmid 25979951?><pub-id pub-id-type="pmid">25979951</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savchenko</surname><given-names>AS</given-names></name><name><surname>Martinod</surname><given-names>K</given-names></name><name><surname>Seidman</surname><given-names>MA</given-names></name><name><surname>Wong</surname><given-names>SL</given-names></name><name><surname>Borissoff</surname><given-names>JI</given-names></name><name><surname>Piazza</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development</article-title>. <source>J Thromb Haemost</source> (<year>2014</year>) <volume>12</volume>:<fpage>860</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1111/jth.12571</pub-id><?supplied-pmid 24674135?><pub-id pub-id-type="pmid">24674135</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>SR</given-names></name><name><surname>Ma</surname><given-names>AC</given-names></name><name><surname>Tavener</surname><given-names>SA</given-names></name><name><surname>McDonald</surname><given-names>B</given-names></name><name><surname>Goodarzi</surname><given-names>Z</given-names></name><name><surname>Kelly</surname><given-names>MM</given-names></name><etal/></person-group>
<article-title>Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood</article-title>. <source>Nat Med</source> (<year>2007</year>) <volume>13</volume>:<fpage>463</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nm1565</pub-id><?supplied-pmid 17384648?><pub-id pub-id-type="pmid">17384648</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>AK</given-names></name><name><surname>Joshi</surname><given-names>MB</given-names></name><name><surname>Philippova</surname><given-names>M</given-names></name><name><surname>Erne</surname><given-names>P</given-names></name><name><surname>Hasler</surname><given-names>P</given-names></name><name><surname>Hahn</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death</article-title>. <source>FEBS Lett</source> (<year>2010</year>) <volume>584</volume>:<fpage>3193</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.febslet.2010.06.006</pub-id><?supplied-pmid 20541553?><pub-id pub-id-type="pmid">20541553</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saffarzadeh</surname><given-names>M</given-names></name><name><surname>Juenemann</surname><given-names>C</given-names></name><name><surname>Queisser</surname><given-names>MA</given-names></name><name><surname>Lochnit</surname><given-names>G</given-names></name><name><surname>Barreto</surname><given-names>G</given-names></name><name><surname>Galuska</surname><given-names>SP</given-names></name><etal/></person-group>
<article-title>Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e32366</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0032366</pub-id><?supplied-pmid 22389696?><pub-id pub-id-type="pmid">22389696</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semeraro</surname><given-names>F</given-names></name><name><surname>Ammollo</surname><given-names>CT</given-names></name><name><surname>Morrissey</surname><given-names>JH</given-names></name><name><surname>Dale</surname><given-names>GL</given-names></name><name><surname>Friese</surname><given-names>P</given-names></name><name><surname>Esmon</surname><given-names>NL</given-names></name><etal/></person-group>
<article-title>Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4</article-title>. <source>Blood</source> (<year>2011</year>) <volume>118</volume>:<fpage>1952</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2011-03-343061</pub-id><?supplied-pmid 21673343?><pub-id pub-id-type="pmid">21673343</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>TJ</given-names></name><name><surname>Vu</surname><given-names>TT</given-names></name><name><surname>Swystun</surname><given-names>LL</given-names></name><name><surname>Dwivedi</surname><given-names>DJ</given-names></name><name><surname>Mai</surname><given-names>SH</given-names></name><name><surname>Weitz</surname><given-names>JI</given-names></name><etal/></person-group>
<article-title>Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2014</year>) <volume>34</volume>:<fpage>1977</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1161/atvbaha.114.304114</pub-id><?supplied-pmid 25012129?><pub-id pub-id-type="pmid">25012129</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>TA</given-names></name><name><surname>Brill</surname><given-names>A</given-names></name><name><surname>Duerschmied</surname><given-names>D</given-names></name><name><surname>Schatzberg</surname><given-names>D</given-names></name><name><surname>Monestier</surname><given-names>M</given-names></name><name><surname>Myers</surname><given-names>DD</given-names><suffix>Jr</suffix></name><etal/></person-group>
<article-title>Extracellular DNA traps promote thrombosis</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2010</year>) <volume>107</volume>:<fpage>15880</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1005743107</pub-id><?supplied-pmid 20798043?><pub-id pub-id-type="pmid">20798043</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brill</surname><given-names>A</given-names></name><name><surname>Fuchs</surname><given-names>TA</given-names></name><name><surname>Savchenko</surname><given-names>AS</given-names></name><name><surname>Thomas</surname><given-names>GM</given-names></name><name><surname>Martinod</surname><given-names>K</given-names></name><name><surname>De Meyer</surname><given-names>SF</given-names></name><etal/></person-group>
<article-title>Neutrophil extracellular traps promote deep vein thrombosis in mice</article-title>. <source>J Thromb Haemost</source> (<year>2012</year>) <volume>10</volume>:<fpage>136</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1111/j.1538-7836.2011.04544.x</pub-id><?supplied-pmid 22044575?><pub-id pub-id-type="pmid">22044575</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Bruhl</surname><given-names>ML</given-names></name><name><surname>Stark</surname><given-names>K</given-names></name><name><surname>Steinhart</surname><given-names>A</given-names></name><name><surname>Chandraratne</surname><given-names>S</given-names></name><name><surname>Konrad</surname><given-names>I</given-names></name><name><surname>Lorenz</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo</article-title>. <source>J Exp Med</source> (<year>2012</year>) <volume>209</volume>:<fpage>819</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20112322</pub-id><?supplied-pmid 22451716?><pub-id pub-id-type="pmid">22451716</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramacciotti</surname><given-names>E</given-names></name><name><surname>Hawley</surname><given-names>AE</given-names></name><name><surname>Farris</surname><given-names>DM</given-names></name><name><surname>Ballard</surname><given-names>NE</given-names></name><name><surname>Wrobleski</surname><given-names>SK</given-names></name><name><surname>Myers</surname><given-names>DD</given-names><suffix>Jr</suffix></name><etal/></person-group>
<article-title>Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis</article-title>. <source>Thromb Haemost</source> (<year>2009</year>) <volume>101</volume>:<fpage>748</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1160/TH08-09-0620</pub-id><?supplied-pmid 19350121?><pub-id pub-id-type="pmid">19350121</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massberg</surname><given-names>S</given-names></name><name><surname>Grahl</surname><given-names>L</given-names></name><name><surname>von Bruehl</surname><given-names>ML</given-names></name><name><surname>Manukyan</surname><given-names>D</given-names></name><name><surname>Pfeiler</surname><given-names>S</given-names></name><name><surname>Goosmann</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases</article-title>. <source>Nat Med</source> (<year>2010</year>) <volume>16</volume>:<fpage>887</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1038/nm.2184</pub-id><?supplied-pmid 20676107?><pub-id pub-id-type="pmid">20676107</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Montfoort</surname><given-names>ML</given-names></name><name><surname>Stephan</surname><given-names>F</given-names></name><name><surname>Lauw</surname><given-names>MN</given-names></name><name><surname>Hutten</surname><given-names>BA</given-names></name><name><surname>Van Mierlo</surname><given-names>GJ</given-names></name><name><surname>Solati</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2013</year>) <volume>33</volume>:<fpage>147</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1161/atvbaha.112.300498</pub-id><?supplied-pmid 23104849?><pub-id pub-id-type="pmid">23104849</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>CM</given-names></name><name><surname>Tetaz</surname><given-names>TJ</given-names></name><name><surname>Andrews</surname><given-names>RK</given-names></name><name><surname>Berndt</surname><given-names>MC</given-names></name></person-group>. <article-title>Binding of the von Willebrand factor A1 domain to histone</article-title>. <source>Thromb Res</source> (<year>1997</year>) <volume>86</volume>:<fpage>469</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1016/S0049-3848(97)00096-0</pub-id><?supplied-pmid 9219327?><pub-id pub-id-type="pmid">9219327</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longstaff</surname><given-names>C</given-names></name><name><surname>Hogwood</surname><given-names>J</given-names></name><name><surname>Gray</surname><given-names>E</given-names></name><name><surname>Komorowicz</surname><given-names>E</given-names></name><name><surname>Varju</surname><given-names>I</given-names></name><name><surname>Varga</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems</article-title>. <source>Thromb Haemost</source> (<year>2016</year>) <volume>115</volume>:<fpage>591</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1160/th15-03-0214</pub-id><?supplied-pmid 26632486?><pub-id pub-id-type="pmid">26632486</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ammollo</surname><given-names>CT</given-names></name><name><surname>Semeraro</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Esmon</surname><given-names>NL</given-names></name><name><surname>Esmon</surname><given-names>CT</given-names></name></person-group>. <article-title>Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation</article-title>. <source>J Thromb Haemost</source> (<year>2011</year>) <volume>9</volume>:<fpage>1795</fpage>&#x02013;<lpage>803</lpage>.<pub-id pub-id-type="doi">10.1111/j.1538-7836.2011.04422.x</pub-id><?supplied-pmid 21711444?><pub-id pub-id-type="pmid">21711444</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oklu</surname><given-names>R</given-names></name><name><surname>Albadawi</surname><given-names>H</given-names></name><name><surname>Watkins</surname><given-names>MT</given-names></name><name><surname>Monestier</surname><given-names>M</given-names></name><name><surname>Sillesen</surname><given-names>M</given-names></name><name><surname>Wicky</surname><given-names>S</given-names></name></person-group>. <article-title>Detection of extracellular genomic DNA scaffold in human thrombus: implications for the use of deoxyribonuclease enzymes in thrombolysis</article-title>. <source>J Vasc Interv Radiol</source> (<year>2012</year>) <volume>23</volume>:<fpage>712</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.jvir.2012.01.072</pub-id><?supplied-pmid 22525027?><pub-id pub-id-type="pmid">22525027</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>R</given-names></name><name><surname>Burke</surname><given-names>T</given-names></name><name><surname>Plow</surname><given-names>EF</given-names></name></person-group>. <article-title>Histone H2B as a functionally important plasminogen receptor on macrophages</article-title>. <source>Blood</source> (<year>2007</year>) <volume>110</volume>:<fpage>3763</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2007-03-079392</pub-id><?supplied-pmid 17690254?><pub-id pub-id-type="pmid">17690254</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>TA</given-names></name><name><surname>Brill</surname><given-names>A</given-names></name><name><surname>Wagner</surname><given-names>DD</given-names></name></person-group>. <article-title>Neutrophil extracellular trap (NET) impact on deep vein thrombosis</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2012</year>) <volume>32</volume>:<fpage>1777</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1161/ATVBAHA.111.242859</pub-id><?supplied-pmid 22652600?><pub-id pub-id-type="pmid">22652600</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz</surname><given-names>JA</given-names></name><name><surname>Fuchs</surname><given-names>TA</given-names></name><name><surname>Jackson</surname><given-names>TO</given-names></name><name><surname>Kremer Hovinga</surname><given-names>JA</given-names></name><name><surname>Lammle</surname><given-names>B</given-names></name><name><surname>Henke</surname><given-names>PK</given-names></name><etal/></person-group>
<article-title>Plasma DNA is elevated in patients with deep vein thrombosis</article-title>. <source>J Vasc Surg Venous Lymphat Disord</source> (<year>2013</year>) <volume>1</volume>:<fpage>341</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.jvsv.2012.12.002</pub-id><?supplied-pmid 24187669?><pub-id pub-id-type="pmid">24187669</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelmann</surname><given-names>B</given-names></name><name><surname>Massberg</surname><given-names>S</given-names></name></person-group>. <article-title>Thrombosis as an intravascular effector of innate immunity</article-title>. <source>Nat Rev Immunol</source> (<year>2013</year>) <volume>13</volume>:<fpage>34</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1038/nri3345</pub-id><?supplied-pmid 23222502?><pub-id pub-id-type="pmid">23222502</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>AC</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group>
<article-title>Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis</article-title>. <source>J Thromb Haemost</source> (<year>2008</year>) <volume>6</volume>:<fpage>415</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1111/j.1538-7836.2007.02865.x</pub-id><pub-id pub-id-type="pmid">18088344</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Qi</surname><given-names>H</given-names></name><name><surname>Kan</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>Neutrophil extracellular traps promote hypercoagulability in patients with sepsis</article-title>. <source>Shock</source> (<year>2017</year>) <volume>47</volume>:<fpage>132</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1097/shk.0000000000000741</pub-id><?supplied-pmid 27617671?><pub-id pub-id-type="pmid">27617671</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varju</surname><given-names>I</given-names></name><name><surname>Longstaff</surname><given-names>C</given-names></name><name><surname>Szabo</surname><given-names>L</given-names></name><name><surname>Farkas</surname><given-names>AZ</given-names></name><name><surname>Varga-Szabo</surname><given-names>VJ</given-names></name><name><surname>Tanka-Salamon</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment</article-title>. <source>Thromb Haemost</source> (<year>2015</year>) <volume>113</volume>:<fpage>1289</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1160/TH14-08-0669</pub-id><?supplied-pmid 25789443?><pub-id pub-id-type="pmid">25789443</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Si</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Ma</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease</article-title>. <source>Thromb Haemost</source> (<year>2016</year>) <volume>115</volume>:<fpage>738</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1160/TH15-09-0710</pub-id><?supplied-pmid 26660948?><pub-id pub-id-type="pmid">26660948</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>YM</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>MH</given-names></name></person-group>. <article-title>Promotion of hypercoagulability in antineutrophil cytoplasmic antibody-associated vasculitis by C5a-induced tissue factor-expressing microparticles and neutrophil extracellular traps</article-title>. <source>Arthritis Rheumatol</source> (<year>2015</year>) <volume>67</volume>:<fpage>2780</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1002/art.39239</pub-id><?supplied-pmid 26097236?><pub-id pub-id-type="pmid">26097236</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konig</surname><given-names>MF</given-names></name><name><surname>Andrade</surname><given-names>F</given-names></name></person-group>. <article-title>A critical reappraisal of neutrophil extracellular traps and NETosis mimics based on differential requirements for protein citrullination</article-title>. <source>Front Immunol</source> (<year>2016</year>) <volume>7</volume>:<fpage>461</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2016.00461</pub-id><?supplied-pmid 27867381?><pub-id pub-id-type="pmid">27867381</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longstaff</surname><given-names>C</given-names></name><name><surname>Varju</surname><given-names>I</given-names></name><name><surname>Sotonyi</surname><given-names>P</given-names></name><name><surname>Szabo</surname><given-names>L</given-names></name><name><surname>Krumrey</surname><given-names>M</given-names></name><name><surname>Hoell</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones</article-title>. <source>J Biol Chem</source> (<year>2013</year>) <volume>288</volume>:<fpage>6946</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M112.404301</pub-id><?supplied-pmid 23293023?><pub-id pub-id-type="pmid">23293023</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogel</surname><given-names>B</given-names></name><name><surname>Shinagawa</surname><given-names>H</given-names></name><name><surname>Hofmann</surname><given-names>U</given-names></name><name><surname>Ertl</surname><given-names>G</given-names></name><name><surname>Frantz</surname><given-names>S</given-names></name></person-group>. <article-title>Acute DNase1 treatment improves left ventricular remodeling after myocardial infarction by disruption of free chromatin</article-title>. <source>Basic Res Cardiol</source> (<year>2015</year>) <volume>110</volume>:<fpage>15</fpage>.<pub-id pub-id-type="doi">10.1007/s00395-015-0472-y</pub-id><?supplied-pmid 25702039?><pub-id pub-id-type="pmid">25702039</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carestia</surname><given-names>A</given-names></name><name><surname>Kaufman</surname><given-names>T</given-names></name><name><surname>Rivadeneyra</surname><given-names>L</given-names></name><name><surname>Landoni</surname><given-names>VI</given-names></name><name><surname>Pozner</surname><given-names>RG</given-names></name><name><surname>Negrotto</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets</article-title>. <source>J Leukoc Biol</source> (<year>2016</year>) <volume>99</volume>:<fpage>153</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.3A0415-161R</pub-id><?supplied-pmid 26320263?><pub-id pub-id-type="pmid">26320263</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schettert</surname><given-names>IT</given-names></name><name><surname>Pereira</surname><given-names>AC</given-names></name><name><surname>Lopes</surname><given-names>NH</given-names></name><name><surname>Hueb</surname><given-names>WA</given-names></name><name><surname>Krieger</surname><given-names>JE</given-names></name></person-group>. <article-title>Association between ADAMTS13 polymorphisms and risk of cardiovascular events in chronic coronary disease</article-title>. <source>Thromb Res</source> (<year>2010</year>) <volume>125</volume>:<fpage>61</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.thromres.2009.03.008</pub-id><?supplied-pmid 19427680?><pub-id pub-id-type="pmid">19427680</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narasimhulu</surname><given-names>CA</given-names></name><name><surname>Vardhan</surname><given-names>S</given-names></name></person-group>. <article-title>Therapeutic potential of <italic>Ocimum tenuiflorum</italic> as MPO inhibitor with implications for atherosclerosis prevention</article-title>. <source>J Med Food</source> (<year>2015</year>) <volume>18</volume>:<fpage>507</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1089/jmf.2014.0125</pub-id><?supplied-pmid 25764050?><pub-id pub-id-type="pmid">25764050</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Sukhova</surname><given-names>GK</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ozaki</surname><given-names>K</given-names></name><name><surname>Lesner</surname><given-names>A</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Cathepsin G deficiency reduces periaortic calcium chloride injury-induced abdominal aortic aneurysms in mice</article-title>. <source>J Vasc Surg</source> (<year>2015</year>) <volume>62</volume>:<fpage>1615</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1016/j.jvs.2014.06.004</pub-id><?supplied-pmid 25037606?><pub-id pub-id-type="pmid">25037606</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dol-Gleizes</surname><given-names>F</given-names></name><name><surname>Paumelle</surname><given-names>R</given-names></name><name><surname>Visentin</surname><given-names>V</given-names></name><name><surname>Mares</surname><given-names>AM</given-names></name><name><surname>Desitter</surname><given-names>P</given-names></name><name><surname>Hennuyer</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2009</year>) <volume>29</volume>:<fpage>12</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1161/ATVBAHA.108.168757</pub-id><?supplied-pmid 18845788?><pub-id pub-id-type="pmid">18845788</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pendu</surname><given-names>R</given-names></name><name><surname>Terraube</surname><given-names>V</given-names></name><name><surname>Christophe</surname><given-names>OD</given-names></name><name><surname>Gahmberg</surname><given-names>CG</given-names></name><name><surname>de Groot</surname><given-names>PG</given-names></name><name><surname>Lenting</surname><given-names>PJ</given-names></name><etal/></person-group>
<article-title>P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor</article-title>. <source>Blood</source> (<year>2006</year>) <volume>108</volume>:<fpage>3746</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2006-03-010322</pub-id><?supplied-pmid 16926295?><pub-id pub-id-type="pmid">16926295</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osterud</surname><given-names>B</given-names></name></person-group>. <article-title>Tissue factor/TFPI and blood cells</article-title>. <source>Thromb Res</source> (<year>2012</year>) <volume>129</volume>:<fpage>274</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.thromres.2011.11.049</pub-id><?supplied-pmid 22197177?><pub-id pub-id-type="pmid">22197177</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chackalamannil</surname><given-names>S</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name></person-group>
<article-title>Thrombin receptor (PAR-1) antagonists as novel antithrombotic agents</article-title>. <source>Expert Opin Ther Pat</source> (<year>2006</year>) <volume>16</volume>:<fpage>493</fpage>&#x02013;<lpage>505</lpage>.<pub-id pub-id-type="doi">10.1517/13543776.16.4.493</pub-id><pub-id pub-id-type="pmid">20144050</pub-id></mixed-citation></ref></ref-list></back></article>